Allergy/Imm Medical News about Toxoplasma gondii

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Spiramycin Treatment of Toxoplasma gondii Infection in Pregnant Women Impairs the Production and the Avidity Maturation of T. gondii-Specific Immunoglobulin G Antibodies
Clinical and Vaccine Immunology, 10/13/09

Meroni V et al. – The Toxoplasma gondii–specific IgG antibody and the T. gondii–specific IgG AI were significantly delayed in pregnant women receiving therapy compared to nonpregnant, untreated controls, and the findings were consistent with the results of assays from two different manufacturers. The T. gondii–specific IgG AI increased in pregnant women after they gave birth. Avidity maturation is delayed during pregnancy and treatment, and low–avidity antibodies in pregnant women within 3 to 4 months cannot be taken as a sign of infection.

<< Previous
Live Birth Rate According to Maternal Age and Previous Number of...

Next >>
Variation in T-SPOT.TB Spot Interpretation between Independent...